Endoscopy Ultrasound Market to Reach Nearly US$ 1.85 Billion by 2032, U.S. and China Lead Market Growth

The global endoscopy ultrasound market is on an upward growth trajectory, expected to expand from US$ 1.06 billion in 2022 to US$ 1.85 billion by 2032. This marks a solid compound annual growth rate (CAGR) of 5.7%, driven by increasing cases of gastrointestinal (GI) cancers and the growing adoption of minimally invasive diagnostic procedures across the globe.

Endoscopic ultrasound (EUS) has emerged as a key tool in modern diagnostics, particularly in the detection and treatment of GI disorders, pancreatic conditions, and oncology. The increasing demand for precise imaging and diagnosis, combined with affordability compared to conventional alternatives like Endoscopic Retrograde Cholangiopancreatography (ERCP), is positioning EUS at the forefront of medical imaging innovations.

Browse Full Report: https://www.factmr.com/report/4689/endoscopy-ultrasound-market

Rise in GI Cancer Cases and Technological Breakthroughs Powering Market Momentum

One of the primary growth drivers in the market is the growing incidence of GI cancers globally. According to the American Cancer Society, pancreatic cancer alone is expected to be diagnosed in over 62,000 individuals in 2022, with nearly 50,000 fatalities, highlighting the urgent need for early diagnosis. Additionally, liver cancer ranks among the most prevalent cancers in Asia, particularly in China, which is contributing significantly to regional demand for endoscopic ultrasound procedures.

Innovations in EUS devices-such as elastography and contrast-enhanced EUS (CE-EUS)-are pushing the envelope of non-invasive diagnostics. The market has also seen increased interest in high-frequency ultrasound and integration of enhanced imaging technologies like the Vevo MD clinical ultrasound system by FUJIFILM Corporation. These innovations have broadened EUS applications beyond oncology into new domains such as pulmonary diagnostics and liver disease assessments.

U.S. and China Lead Market Growth with Robust CAGR

North America continues to dominate the global endoscopy ultrasound market, with the U.S. projected to maintain a 5.7% CAGR from 2022 to 2032. The U.S. market benefits from a high prevalence of GI-related illnesses, increased adoption of advanced diagnostic tools, and an established healthcare infrastructure supporting EUS adoption.

China, on the other hand, is rapidly becoming a key player in the Asia-Pacific region, expected to register a CAGR of 5.7% during the same period. The country's large pool of GI and pancreatic cancer patients, along with improving healthcare penetration and training programs for clinicians, is driving demand for endoscopy ultrasound systems.

Other prominent countries contributing to market growth include Japan (5.5% CAGR), South Korea (5.6%), and the U.K. (5%). Together, these regions are witnessing increased adoption of minimally invasive diagnostic tools and heightened awareness about early-stage cancer detection.

Product Demand: Endoscopes Dominate While Needles See Accelerated Growth

Among the product categories, endoscopes are anticipated to capture the largest share of the market, growing at a 5.8% CAGR. This growth is fueled by the continual evolution in imaging quality and usability. Meanwhile, endoscopy ultrasound needles-particularly those used in aspiration and biopsy procedures-are showing the fastest growth due to their cost-effectiveness and single-use nature.

From an application standpoint, the oncology segment remains the primary growth contributor, owing to the rising global burden of GI malignancies and the increased efficacy of EUS in cancer staging and diagnosis. Other key applications include upper and lower GI diagnostics and pancreatic conditions.

For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=4689

Competitive Landscape: Innovation and Strategic Partnerships Driving Market Consolidation

The endoscopy ultrasound market is characterized by a strong presence of established players like Olympus Corporation, FUJIFILM Corporation, and PENTAX Medical (HOYA Corporation). These companies are investing heavily in research and product innovation. Olympus, for example, has made strides with the EZ Shot 3 Plus and advanced processors like the ProSound F75 and EU-ME2.

In 2021, Olympus partnered with Hitachi Ltd. for a five-year collaboration to co-develop endoscopic ultrasound systems. Hitachi continues to supply diagnostic ultrasound systems and components for Olympus' EUS solutions, strengthening the company's product portfolio and enhancing its technological edge.

FUJIFILM Corporation, another key market player, continues to expand its imaging portfolio with products such as the EG-530 UR and SP-900. The company's FDA-approved Vevo MD has set a new benchmark in ultra-high frequency ultrasound imaging

Check out More Related Studies Published by Fact.MR Research:

Immunodermatology Market - https://www.factmr.com/report/immunodermatology-market

Nose Reconstruction Market - https://www.factmr.com/report/nose-reconstruction-market

BRAF-MEK Inhibitors Market - https://www.factmr.com/report/braf-mek-inhibitors-market

Fusion Protein Biosimilars Market - https://www.factmr.com/report/fusion-protein-biosimilars-market

Contact Us:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Sales Team : sales@factmr.com

About Us:
Fact.MR is a distinguished market research company renowned for its comprehensive market reports and invaluable business insights. As a prominent player in business intelligence, we deliver deep analysis, uncovering market trends, growth paths, and competitive landscapes. Renowned for its commitment to accuracy and reliability, we empower businesses with crucial data and strategic recommendations, facilitating informed decision-making and enhancing market positioning.

This release was published on openPR.